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HLA B*5701-Positive Long-Term Nonprogressors/Elite Controllers Are
Not Distinguished from Progressors by the Clonal Composition of
HIV-Specific CD8 T Cells
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David A. Price,b,c Daniel C. Douek,b Stephen A. Migueles,a and Mark Connorsa
HIV-Specific Immunity Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland,
USAa; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USAb; Institute of Infection and
Immunity, Cardiff University School of Medicine, Cardiff, Wales, United Kingdomc; and Computational Biology Group, Centre for Vascular Research, University of New
South Wales, Kensington, Australiad
To better understand the qualitative features of effective human immunodeficiency virus (HIV)-specific immunity, we examined
the TCR clonal composition of CD8 T cells recognizing conserved HIV p24-derived epitopes in HLA-B*5701-positive long-
term nonprogressors/elite controllers (LTNP/EC) and HLA-matched progressors. Both groups displayed oligoclonal HLA-
B5701-restricted p24-specific CD8 T-cell responses with similar levels of diversity and few public clonotypes. Thus, HIV-
specific CD8 T-cell responses in LTNP/EC are not differentiated from those of progressors on the basis of clonal diversity or
TCR sharing.
Understanding natural immunologic control of human immu-nodeficiency virus (HIV)may provide important insights for
the development of vaccines and immunotherapies. Rare long-
term nonprogressors/elite controllers (LTNP/EC)maintain dura-
ble restriction of HIV replication without antiretroviral therapy
(25). Evidence suggesting that HIV-specific CD8 T cells mediate
this control (13) includes a dramatic overrepresentation of the
HLA-B*5701 allele (8, 12, 19, 21, 29, 33, 37) and a CD8 T-cell
response focused on HLA-B5701-restricted peptides (11, 29).
Similarly, LTNP/EC rhesus macaques are enriched for the Mamu
B*08 or B*17 alleles (22, 43) and lose control of simian immuno-
deficiency virus (SIV) replication following antibody-mediated
CD8 T-cell depletion (9). HIV-specific CD8 T cells in
LTNP/EC also show a greater capacity to suppressHIV replication
or kill autologous HIV-infected CD4 T cells than those of pro-
gressors (14, 27, 28, 30, 37). Collectively, these data suggest that
greater HIV control in LTNP/EC than in progressors is likely me-
diated by qualitative differences in their CD8 T-cell responses.
It has been speculated that favorableHLAmoleculesmay select
for a diverse repertoire of T-cell receptor (TCR) clonotypes capa-
ble of limiting HIV mutational escape (5, 17, 18, 20, 23, 38). Fa-
vorable HLA molecules might preferentially select for “public
clonotypes” (10, 34, 38–40), which are shared among multiple
individuals and may constitute particularly effective CD8 T-cell
responses (1, 2, 15). In the present study, we compared for the first
time the clonalities of CD8 T cells targeting the same immuno-
dominant HIV epitopes in HLA-B*5701 LTNP/EC and in pro-
gressors to better understand qualitative features of an effective
HIV-specific CD8 T-cell response.
Subjects signed institutional review board-approved informed
consent forms andwere categorized as LTNP/ECor progressors as
previously defined (28, 29). Three progressors who had had ele-
vated HIV RNA levels (10,000 copies/ml) prior to initiating an-
tiretroviral therapy (ART) donated peripheral blood mononu-
clear cells (PBMC) while receiving ART yet had persistently
detectable viremia due to erratic compliance with their regimens
(Table 1). PBMC were stained with HLA-B5701 tetramers com-
plexed to the HIV Gag p24 epitopes ISPRTLNAW (IW9; amino
acids [aa] 147 to 155), KAFSPEVIPMF (KF11; aa 162 to 172), or
QASQEVKNW (QW9; aa 308 to 316) (Beckman Coulter, San Di-
ego, CA) and then surface stained with antibodies to CD3, CD8,
CD57, CD25, CD27, CD28, HLA-DR, CD45RO, CD57, and
CCR7 (BD Biosciences, San Jose, CA) prior to flow cytometry
analysis (16, 28). Tetramer-positive CD8 T cells were also sorted
at98% purity by flow cytometry, and all expressed TCR gene
products were amplified and characterized without bias using a
nonnested template-switch-anchored reverse transcription-PCR
(RT-PCR) (6, 35). Medians and correlations were analyzed using
the Wilcoxon two-sample test and the Spearman rank method,
respectively. The Bonferroni method was used to adjust P values
formultiple testing. Clonotypic diversity was assessed by the stan-
dardized number of clonotypes, which accounts for differences in
the number of TCR sequences obtained per sample, and Simp-
son’s diversity index, which accounts for the clonal dominance
hierarchy and varies between 0 (minimal diversity) and 1 (maxi-
mal diversity) (41).
Between 0.8 and 6.2% of CD8 T cells from 7 HLA-B*5701-
positive LTNP/EC (10 specificities) and 8 progressors (10 speci-
ficities) (Table 1) stained positively with at least one HLA-B5701/
p24 tetramer (Fig. 1A and B and data not shown). No significant
differences were observed between LTNP/EC and progressors
within the tetramer-positive populations regarding activation sta-
tus, costimulation, antigen exposure, or homing (CD25, HLA-
DR, CD27, CD28, CD45RO, CD57, or CCR7 expression) (P 0.5
for all comparisons; data not shown). The predominant pheno-
type of HLA-B5701/p24 tetramer-positive CD8 T cells was
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CD25CD27CD45ROCCR7CD57/ in both groups (data
not shown), consistent with previous reports (4, 7, 16, 32).
In analyses of the clonotypic composition of HLA-B5701/p24
tetramer-positive cells, a mean of 65 clones were examined for
each sorted specificity, representing 1,000 TCR sequences (6,
36). Overall, the immunodominant B5701-restricted HIV p24
epitope-specific CD8 T-cell populations in both groups were
oligoclonal, comprising a median of 6.5 clonotypes (range, 1 to
12) per specificity (Table 2 and Fig. 1A and B). Only the QW9-
specific cells of LTNP/EC4weremonoclonal (Table 2). These data
are consistent with previous observations in chronic human viral
infections (6, 23).
To analyze repertoire diversity, subject 107’s IW9-specific TCR
repertoire (18 TCRs) and subject 101’s KF11-specific repertoire
(14 TCRs) were excluded due to low numbers of sequences. The
remaining data were standardized for sampling differences (41).
There were no significant differences between LTNP/EC and pro-
gressors in either the standardized numbers of epitope-specific
clonotypes per repertoire (P 0.5) (Fig. 2A) or Simpson’s diver-
sity index (P  0.31) (Fig. 2C) for the IW9- and KF11-specific
repertoires. QW9-specific repertoires were omitted from the
comparisons since they were only detected in the LTNP/EC group
(n  3) (Fig. 2B and D). Additionally, there were no significant
correlations between HIV RNA levels and either the number or
diversity of CD8 T-cell clonotypes per repertoire (P 0.5 for all
correlations; data not shown).
We next examined whether there were public TCR clonotypes
shared between these patients or with prior reports (10, 38, 44).
Only 2 public clonotypes were identified in LTNP/EC that were
not shared with patients in this study but that had previously been
reported in two progressors (Table 2) (44). In progressors, only
two sequences were shared between two individuals and one was
previously reported (Table 2) (44). Thus, public clonotypes were
not a dominant feature of the repertoires of either LTNP/EC or
progressors.
Collectively, these data suggest that the large differences in im-
munologic control between HLA-B*5701-positive LTNP/EC and
progressors are unlikely to be mediated by differences in the TCR
TABLE 1 Patient characteristics
Patient type and no.
HLA class I allele(s)
Yr of
diagnosis
No. of T cells
(cells/l)
Viral load (copies/ml) Tetramer(s)aA B C CD4 CD8
LTNP/EC
4 1,31 8,57 6,7 1985 943 1,012 50 IW9, QW9
7 1,2 57 6 1985 325 342 50 IW9, KF11
33 2,30 13,57 6 1995 1,334 1,557 50 IW9
34 1,2 8,57 6,7 1989 1,523 1,111 50 KF11, QW9
30 31,74 51,57 7,16 1990 306 747 50–58 KF11
6 11,30 52,57 7,12 1986 737 998 50–152 QW9
8 11,23 44,57 4,6 1985 490 1,033 50–567 IW9, KF11
Progressors (untreated)
35 2,3 57 6,7 2000 1,144 1,220 1,800 KF11
20 1 52,57 6,12 1985 1,068 1,091 25,017 KF11
106 3,30 18,57 5,18 1986 420 1,382 24,564 IW9, KF11
131 2,11 35,57 4,6 1989 421 1,082 76,038 IW9, KF11
107 3 40,57 3,7 1987 405 1,418 90,130 IW9, KF11
Progressors (treated)
105 2,80 8,57 2,7 1990 616 1,026 2,473 KF11
101 1,31 51,57 6,15 1986 419 992 3,421 KF11
103 2,11 55,57 3,6 1991 653 1,130 3,968 KF11
a HLA-B5701/HIV Gag p24 tetramers. IW9, ISPRTLNAW (positions 147 to 155); KF11, KAFSPEVIPMF (162 to 172); QW9, QASQEVKNW (308 to 316).
FIG 1 Clonal composition ofHLA-B5701/HIVGagp24 tetramer-positiveCD8
T-cell populations in LTNP/EC and progressors. (A and B) Summary data show-
ing the frequencies of each TCR clonotype (Table 2) relative to the frequencies of
the corresponding HLA B5701/HIVGag p24 tetramer-positive CD8 T cells in 7
HLA-B*5701-positiveLTNP/EC(A)and8HLA-B*5701-positiveprogressors (B).
ThreeHLA-B5701/HIVGag p24 tetramers containing B57 bound to one of three
immunodominantGagp24-derivedepitopes (I, IW9;K,KF11; andQ,QW9)were
used to stain and sort antigen-specificCD8Tcells for clonotypic analysis.Results
for two different specificities are shown for patients 4, 8, 34, 107, and 131. The
numbers above each stacked bar denote the total number of clonotypes for the
depicted epitope-specific CD8 T-cell population.
Clonal Diversity between LTNP/EC and Progressors
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TABLE 2 HLA-B5701-restricted HIV Gag p24-specific CD8 TCR repertoiresa
a I, K, and Q represent HLA-B5701-restricted CD8 T-cell repertoires specific for Gag epitopes IW9, KF11, and QW9,
respectively, for a given patient. Public clonotypes were defined as identical TCR amino acid sequences observed in
more than one individual with reference to an extensive database, including both previously reported and unpublished
sequences. Sequences in gray are public clonotypes that are also found in prior reports. Clonotypes shared between
patients in this report are shown in color. TRBV, TCR variable allele; CDR3, complementarity-determining region 3;
TRBJ, TCR joining allele.
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repertoire of immunodominant HIV-specific CD8 T-cell popu-
lations. We observed similar clonotype numbers and diversity in
these cohorts regardless of viral load or specificity. The trend to-
ward greater TCR polyclonality in progressors than in LTNP/EC
might be explained by the recruitment of a more polyclonal re-
sponse in the context of higher viral loads in the former group.
In priorwork, it has been suggested that greater clonal diversity
within the HIV-specificmemory CD8 T-cell repertoire mayme-
diate superior control of HIV (17, 18, 24, 38). It has been further
proposed that protective HLA class I alleles might mediate their
effect through thymic deletion of fewer self-reactive clones, pro-
viding a more diverse naïve repertoire (20). In either case, it is
hypothesized that greater clonal diversity might mediate superior
control through improved recognition of peptide variants. How-
ever, many prior studies did not include true LTNP/EC and did
not compare responses within a givenHLA and specificity (17, 18,
24, 38). In addition, differences in TCR contact residues within
targeted epitopes, suggesting differential abilities to contain non-
anchor position variation, have not been observed between
B*5701-positive LTNP/EC and progressors (3, 26, 31). Therefore,
if TCR clonal diversity were an important parameter differentiat-
ing LTNP/EC from progressors, some detectable difference in
clonality between these groups would be expected, considering
the vast differences in their capacity to control HIV replication.
It has also been suggested that LTNP/EC may possess public
clonotypes that preferentially contain HIV (10, 34, 44). Public-
clonotype HIV-specific CD8 T cells with high functional avidity
that could be particularly efficaciousmight be selected inmultiple
individuals (15). However, we did not observe significant num-
bers of public clonotypes in either LTNP/EC or progressors, in
contrast to prior results in which a single clonotype was found in
theKF11-specific responses of 3HLAB*5701-positive donors (10,
44). Furthermore, we previously detected no differences between
LTNP/EC and progressors in the avidities of gamma interferon
(IFN-)-secreting HIV-specific CD8 T cells responding to cog-
nate peptides (26, 27). Selection of Gag-specific public clonotypes
in the rhesus macaque-SIV infection model has been observed to
correlate inverselywith subsequent viral load (34).However, these
studies were conducted during acute SIV infection. It is likely that
the forces governing public clonotype selection in acute lentiviral
infection or vaccinationmay differ from those involved in chronic
HIV infection. It remains possible that additional study of HIV-
specific CD8T-cell clonotypes in the setting of acute infection or
vaccination (42) may further our understanding of immunologic
control of HIV and other chronic viral infections in humans.
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